Hippophae rhamnoides leaf homogeneous polysaccharide as well as preparation method and application thereof

Through the multi-step extraction and separation process of sea buckthorn leaves, acidic homogeneous polysaccharides with immunomodulatory activity were obtained, which solved the gap in the study of polysaccharide immunomodulatory activity in sea buckthorn leaves, and achieved effective regulation of macrophages and mouse immune system, significantly Reduce inflammatory factors.

CN119060208APending Publication Date: 2024-12-03XINJIANG AGRI UNIV
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202410974464.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-19
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

There is a lack of research on homogeneous polysaccharides in the prior art, especially their immunomodulatory activity, and it is difficult to develop sea buckthorn leaves for immunomodulatory functional foods and drugs.

Method used

After decolorization and degreasing of dried sea buckthorn leaves, treatment with ethanol and petroleum ether, hot water extraction and dialysis were performed, combined with macroporous resin and DEAE Sepharose Fast Flow agarose gel column to obtain acidic homogeneous polysaccharides, which were further passed through Superdex-75 The glycan gel column was isolated to obtain a sea buckthorn leaf homogeneous polysaccharide with immunomodulatory activity.

Benefits of technology

The acidic homogeneous polysaccharide was isolated and purified from sea buckthorn leaves, with a structure of 14.18×103Da, consisting of rhamnosaccharide, glucuronic acid, galacturonic acid, galactose and arabinose, which can be promoted in the range of 0.015625~1mg/mL. The proliferation and secretion of inflammatory factors of macrophages significantly reduce the level of inflammatory factors in mice's serum and alleviate the immune suppression and intestinal inflammation induced by cyclophosphamide.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119060208A_ABST
    Figure CN119060208A_ABST
Patent Text Reader

Abstract

The invention discloses a hippophae rhamnoides leaf homogeneous polysaccharide as well as a preparation method and application thereof. The method comprises the following steps: drying hippophae rhamnoides leaves, crushing, decolorizing with 85% ethanol, degreasing with petroleum ether, extracting with hot water, centrifugally concentrating, dialyzing with a dialysis bag (8000-14000 Da), precipitating with absolute ethyl alcohol, centrifuging, and freeze-drying in vacuum to prepare crude polysaccharide of the hippophae rhamnoides leaves, further purifying the crude polysaccharide with AB-8 macroporous resin to obtain the hippophae rhamnoides leaf polysaccharide. And carrying out separation and purification by adopting an anion exchange DEAE Sepharose Fast Flow chromatographic column and a Superdex-75 gel column chromatography method, so as to obtain the hippophae rhamnoides leaf homogeneous polysaccharide. The molecular weight of the hippophae rhamnoides leaf homogeneous polysaccharide obtained by the method is 14.18 * 10 < 3 > Da, the hippophae rhamnoides leaf homogeneous polysaccharide is composed of rhamnose, glucuronic acid, galacturonic acid, galactose and arabinose, and the molar ratio of monosaccharides of the hippophae rhamnoides leaf homogeneous polysaccharide is 3.20: 2.63: 83.24: 6.04: 4.81. The hippophae rhamnoides leaf homogeneous polysaccharide prepared by the method disclosed by the invention has immunomodulatory activity, can be used for preparing a medicine for enhancing the immunomodulatory effect, and has better application prospect and market value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of preparing seabuckthorn leaf polysaccharide, and in particular to preparing plant polysaccharide with immunomodulatory activity. Background Art

[0002] Seabuckthorn is the dried mature fruit of Hippophae rhamnoides L., a plant of the Elaeagnaceae family. It is harvested in autumn and winter when the fruit is ripe or frozen. Seabuckthorn is widely distributed in northwest my country and is rich in resources. It is planted on a large scale in northern Xinjiang, and there are large-scale planting bases in southern Xinjiang Kezhou, Aksu Wensu County and other places. Seabuckthorn is recorded in the first volume of the Chinese Pharmacopoeia in 2020. It is sour, astringent and warm in nature. It belongs to the spleen, stomach, lung and heart meridians. It has the effects of strengthening the spleen and digestion, relieving cough and expectoration, promoting blood circulation and dispersing blood stasis. It is mainly used for the treatment of spleen deficiency, poor appetite, abdominal pain due to food accumulation, cough and sputum, chest pain, amenorrhea due to congestion, and swelling due to falls. Seabuckthorn is rich in flavonoids, oils, polysaccharides, terpenes, vitamins and tannins, and has activities such as immunomodulation, anti-inflammatory, antioxidant, liver protection, anti-aging, anti-tumor, improvement of intestinal flora, antibacterial and anti-cardiovascular disease.

[0003] Polysaccharides have immunomodulatory effects on various immune organs and immune cells, and the wide range of biological activities of polysaccharides are inseparable from their immunomodulatory ability. Various biological activities are achieved by improving the body's immune function. Chinese medicine polysaccharides not only promote the function of immune cells, but also promote the release of various cytokines, improve the body's immunity through immune enhancement, and achieve anti-inflammatory effects. Plant polysaccharides can regulate the growth, differentiation or migration of various immune cells, including macrophages, natural killer cells, neutrophils, etc. in nonspecific immunity and specific immune cells such as T / B lymphocytes, thereby enhancing the body's cellular immune activity to relieve inflammation.

[0004] The research on the preparation of seabuckthorn leaf polysaccharide mainly includes: CN201310474012.3 Chinese patent document discloses a technology for preparing seabuckthorn leaf polysaccharide, which is mainly used to enhance human immunity, anti-aging and antibacterial effects. CN201310441323.X Chinese patent document discloses a method for preparing seabuckthorn polysaccharide soft capsules.

[0005] The research on the preparation of immune-regulating drugs, health products or foods from seabuckthorn leaves mainly includes: CN201711364309.9 Chinese patent discloses a method for preparing a fermented seabuckthorn composition that can improve intestinal immunity. The invention degrades macromolecular substances in seabuckthorn leaves and seabuckthorn fruits by biological means, provides nutrition and material basis for the metabolism of beneficial microorganisms, and combines the rich antioxidant active substances in seabuckthorn leaves. The beneficial bacteria are firmly wrapped in the dry technology, which can effectively improve the activity of beneficial bacteria to reach the intestine and produce effective antioxidant properties; the present invention can be applied to products that improve intestinal immunity. CN202110622682.X Chinese patent discloses a Lingzhi Valley seabuckthorn fermented vinegar that can stimulate the self-healing ability of the human body. The fermented vinegar has the functions of aiding digestion, improving the physiological function of cell tissues and regulating immune function. CN201911009254.9 Chinese patent discloses a health-care seabuckthorn tea and its modification method. The seabuckthorn tea has the common effects of refreshing and quenching thirst of tea, and has antioxidant and immunoregulatory abilities.

[0006] In conclusion, from the above research content, it can be seen that there are few reports on the immunomodulatory activity of seabuckthorn leaves and the preparation of their polysaccharide components, especially on the immunomodulatory activity of seabuckthorn leaf uniform polysaccharides. Finding immunomodulators from natural plants is a new direction for the development of modern medicine and food industry; studying the immunomodulatory effects of polysaccharides and their derivatives and developing new immunoenhancers are of great practical significance. This study can provide a reference for the application and development of seabuckthorn leaf polysaccharides in immunomodulatory functional foods. Summary of the invention

[0007] The purpose of the present invention is to provide a uniform seabuckthorn leaf polysaccharide and a preparation method thereof.

[0008] The invention also provides application of seabuckthorn leaf polysaccharide in immunomodulatory medicine, health care product or food.

[0009] The method for preparing the uniform polysaccharide from seabuckthorn leaves of the present invention comprises the following specific steps:

[0010] (a) The dried seabuckthorn leaves were crushed and passed through a 100-mesh sieve. After reflux in ethanol at 90° C. for 2 hours, the powder was naturally air-dried. This process was repeated three times until the color of the ethanol layer became lighter.

[0011] (b) The air-dried powder in step (a) was stirred with petroleum ether at room temperature for 2 hours and then air-dried. The process was repeated three times until the petroleum ether layer was colorless.

[0012] (c) The air-dried powder in step (b) is extracted with hot water at 95-100° C. for 2 hours. After extraction, the mixture is filtered with three layers of gauze and concentrated.

[0013] (d) The concentrated solution in step (c) is centrifuged and dialyzed for 48 hours. After the dialysis, the solution is precipitated with anhydrous ethanol, centrifuged, and vacuum-freeze-dried to obtain crude seabuckthorn leaf polysaccharide.

[0014] (e) The crude polysaccharide in step (d) is dissolved in distilled water, centrifuged, and deproteinized by passing through AB-8 macroporous resin. The deproteinized solution is separated and purified by an anion exchange column, and eluted with distilled water, 0.2 mol / L and 0.4 mol / L NaCl solutions as eluents, respectively, and collected by an automatic collector to draw an elution curve. Samples are collected according to the position of the elution peak, concentrated, and the distilled water elution part (neutral polysaccharide) is directly freeze-dried, and the NaCl solution elution part (acidic polysaccharide) is dialyzed for 48 hours and then freeze-dried.

[0015] (f) Weighing 100 mg of the main polysaccharide after freeze-drying in step (e), separating and purifying it through a gel column, eluting it with distilled water, collecting it with an automatic collector, drawing an elution curve, collecting samples according to the elution peak, and freeze-drying it to obtain a uniform polysaccharide.

[0016] The uniform seabuckthorn leaf polysaccharide of the present invention is prepared by decolorizing and defatting the dried seabuckthorn leaves, extracting with water and precipitating with alcohol to obtain crude polysaccharide, deproteinizing with macroporous resin, and separating and purifying with DEAE Sepharose Fast Flow agarose gel column and Superdex-75 dextran gel column.

[0017] The application of the seabuckthorn leaf uniform polysaccharide of the present invention refers to the use of the isolated and purified uniform polysaccharide as an active ingredient to enhance the immunomodulatory effect of macrophage RAW264.7;

[0018] The application of the seabuckthorn leaf uniform polysaccharide described in the present invention also refers to the main acidic polysaccharide component separated by DEAE Sepharose Fast Flow chromatography column as an active ingredient for alleviating the immunosuppression effect of cyclophosphamide-induced immunosuppressed mice, and for preparing drugs, health products or foods with immunomodulatory effects.

[0019] Compared with the prior art, the present invention has the following significant beneficial effects:

[0020] The present invention separates and purifies an acidic homogeneous polysaccharide from seabuckthorn leaves for the first time, and obtains a structural molecular weight of 14.18×10 3 Da, composed of rhamnose, glucuronic acid, galacturonic acid, galactose and arabinose, has a molar ratio of monosaccharides of 3.20:2.63:83.24:6.04:4.81.

[0021] The experimental results show that the uniform polysaccharide of seabuckthorn leaves separated and purified by the present invention has no cytotoxicity to macrophages in the range of 0.015625-1 mg / mL and can promote the proliferation of RAW264.7 cells. At 0.25 mg / mL, it can promote the secretion of inflammatory factors by RAW264.7 cells. The results of RT-qPCR showed that compared with the blank group, there were 1829 genes with clear changes in the seabuckthorn leaf group, including 758 up-regulated genes and 1071 down-regulated genes; KEGG biological pathway enrichment analysis visualized the top 8 pathways with the largest number of participating genes, among which NF-κB and Toll-like receptor signaling pathways are closely related to inflammatory response, and the number of differentially expressed genes included is 27 and 22, respectively. It is preliminarily speculated that the uniform polysaccharide of seabuckthorn leaves can enhance the immunomodulatory effect of mouse RAW264.7 cell line, and its mechanism may be related to NF-κB and Toll-like receptor signaling pathways.

[0022] The experimental results show that the acidic polysaccharide HRLP-Ⅱ isolated and purified from seabuckthorn leaves provided by the present invention can significantly reduce the level of inflammatory factors in mouse serum. The results of short-chain fatty acids show that the HRLP-Ⅱ provided by the present invention can increase the content of short-chain fatty acids such as acetic acid, propionic acid, butyric acid, and isobutyric acid in the intestine. The spleen injury detection results show that the HRLP-Ⅱ provided by the present invention can alleviate the pathological phenomenon of increased inflammatory factors in the spleen of suppressed mice induced by cyclophosphamide. The results of spleen HE staining show that the HRLP-Ⅱ provided by the present invention can effectively improve the spleen injury of immunosuppressed mice induced by cyclophosphamide. The results of spleen flow cytometry show that the HRLP-Ⅱ provided by the present invention can alleviate the pathological phenomenon of increased inflammatory factors in the spleen of immunosuppressed mice induced by cyclophosphamide, and can reduce the probability of viral infection in mice to a certain extent. The results of intestinal injury detection show that the HRLP-Ⅱ provided by the present invention can alleviate the pathological phenomenon of increased inflammatory factors in the intestine of suppressed mice induced by cyclophosphamide. The results of intestinal HE staining show that the HRLP-Ⅱ provided by the present invention alleviates the damage of cyclophosphamide to the intestinal mucosa of mice to a certain extent and protects the integrity of the intestinal mucosa. The intestinal AB-PAS results showed that the HRLP-Ⅱ provided by the present invention alleviated the damage of cyclophosphamide to the intestinal mucus barrier of mice to a certain extent, and maintained the environmental state and health of the intestine. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 The elution curve of the crude polysaccharide of seabuckthorn leaf of the present invention is a DEAE Sepharose Fast Flow anion exchange column;

[0024] Figure 2 It is the elution curve of the Superdex-75 dextran gel column of HRLP-Ⅱ of the present invention;

[0025] Figure 3The infrared spectra of HRLP-Ⅰ, HRLP-Ⅱ and HRLP-Ⅲ are shown;

[0026] Figure 4 The high performance gel permeation chromatogram of the seabuckthorn leaf polysaccharide HRLP-Ⅱ-b of the present invention;

[0027] Figure 5 The monosaccharide composition diagram of the seabuckthorn leaf polysaccharide HRLP-Ⅱ-b of the present invention, Note: A is the chromatogram of the standard product, and B is the chromatogram of HRLP-Ⅱ-b;

[0028] Figure 6 This is a diagram showing the methylation results of the purified polysaccharide HRLP-Ⅱ-b of the present invention;

[0029] Figure 7 The in vitro antioxidant activity ABTS, DPPH and hydroxyl radical scavenging ability, ferrous ion chelating ability and total reducing ability of the purified seabuckthorn leaf polysaccharides HRLP-Ⅰ, HRLP-Ⅱ and HRLP-Ⅲ of the present invention are shown in Figure 1. Note: A is the ABTS diagram, B is the DPPH diagram, C is the hydroxyl radical diagram, D is the ferrous ion chelating diagram, and E is the total reducing ability diagram;

[0030] Figure 8 This is a graph showing the effect of the purified polysaccharide HRLP-Ⅱ-b from seabuckthorn leaves on the survival rate of macrophages RAW264.7;

[0031] Fig. 9 This is a graph showing the detection of the content of TNF-α, IL-4, IFN-γ and IL-10 in the supernatant of macrophage RAW264.7 cells by the purified polysaccharide HRLP-Ⅱ-b from seabuckthorn leaves of the present invention. Note: A is TNF-α, B is IL-4, C is IFN-γ, and D is IL-10.

[0032] Fig.10 This is the overall gene expression diagram (volcano diagram) of the HRLP-Ⅱ-b RT-qPCR method for detecting the expression of cell-related mRNA in the purified polysaccharide from seabuckthorn leaves of the present invention;

[0033] Fig.11 This is a KEGG enrichment analysis diagram (bubble diagram) of the expression of cell-related mRNA detected by RT-qPCR method of the purified polysaccharide HRLP-Ⅱ-b from seabuckthorn leaves of the present invention;

[0034] Fig.12 This is a pathway diagram for detecting cell-related mRNA expression by HRLP-Ⅱ-b RT-qPCR of the purified polysaccharide from seabuckthorn leaves of the present invention. Note: A is the NF-κB signaling pathway, and B is the Toll-like receptor signaling pathway;

[0035] Fig.13This is a differential diagram (heat map) of related pathway genes for detecting cell-related mRNA expression by HRLP-Ⅱ-b RT-qPCR of the purified polysaccharide from seabuckthorn leaves of the present invention. Note: A is the NF-κB signaling pathway, and B is the Toll-like receptor signaling pathway;

[0036] Fig.14 The effect of the purified polysaccharide HRLP-Ⅱ from seabuckthorn leaves on the body weight of immunosuppressed mice induced by cyclophosphamide;

[0037] Fig.15 The effect of the purified polysaccharide HRLP-Ⅱ from seabuckthorn leaves on the inflammatory factors IL-2, IL-4, IL-6, IL-10, IL-17, TNF-ɑ, and IFN-γ in the serum of immunosuppressed mice induced by cyclophosphamide. Note: A is IL-2, B is IL-4, C is IL-6, D is IL-10, E is IL-17, and F is IFN-γ.

[0038] Fig.16 The effect of the purified polysaccharide HRLP-Ⅱ from seabuckthorn leaves on inflammatory factors IL-2, IL-6 and TNF-ɑ in the spleen of immunosuppressed mice induced by cyclophosphamide. Note: A is IL-2, B is IL-6 and C is TNF-ɑ.

[0039] Fig.17 This is the HE staining result of the purified polysaccharide HRLP-Ⅱ from seabuckthorn leaves on the spleen of cyclophosphamide-induced immunosuppressed mice. Note: A is the blank group, B is the model group, C is the positive group, D is the high-dose group, E is the medium-dose group, F is the low-dose group, WP is the white pulp, RP is the red pulp, LN is the lymph node, PLS is the periarterial lymphoid sheath, and MZ is the marginal zone;

[0040] Fig.18 The results of the analysis of the purified polysaccharide HRLP-Ⅱ from seabuckthorn leaves on the primary isolated cells of the spleen of cyclophosphamide-induced immunosuppressed mice. Note: A is the percentage of total T lymphocytes in the antibody, B is the percentage of CD3 cells in the antibody, C is the model group, D is the blank group, E is the positive group, F is the high-dose group, G is the medium-dose group, H is the low-dose group, Q1 is the CD4 - CD8 + , Q2 is CD4 + CD8 + , Q3 is CD4 + CD8 - , Q4 is CD4 - CD8 - ;

[0041] Fig.19The effect of the purified polysaccharide HRLP-Ⅱ from seabuckthorn leaves on the intestinal inflammatory factors IL-2, IL-4, IL-10, IL-17, TNF-α, and IFN-γ in immunosuppressed mice induced by cyclophosphamide. Note: A is IL-2, B is IL-4, C is IL-10, D is IL-17, E is TNF-α, and F is IFN-γ.

[0042] Fig. 20 The results of HE staining of the intestine of cyclophosphamide-induced immunosuppressed mice by the purified polysaccharide HRLP-Ⅱ from seabuckthorn leaves of the present invention, Note: (a) is the jejunum, (b) is the ileum, (c) is the duodenum, (d) is the cecum, A is the model group, B is the blank group, C is the positive group, D is the high-dose group, E is the medium-dose group, and F is the low-dose group;

[0043] Fig.21 The figure shows the results of AB-PAS staining of the intestine of cyclophosphamide-induced immunosuppressed mice by the purified polysaccharide HRLP-Ⅱ from seabuckthorn leaves of the present invention. Note: (a) is the jejunum, (b) is the ileum, (c) is the duodenum, (d) is the cecum, A is the model group, B is the blank group, C is the positive group, D is the high-dose group, E is the medium-dose group, and F is the low-dose group. DETAILED DESCRIPTION

[0044] The present invention is further described below in conjunction with the accompanying drawings and specific examples. The following examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods in the following examples without specifying specific conditions are usually based on conventional conditions or conditions recommended by the manufacturer.

[0045] Example 1: Preparation of uniform polysaccharide from seabuckthorn leaves:

[0046] 1.1 Extraction of crude polysaccharides from seabuckthorn leaves: Seabuckthorn leaves are dried, crushed, sieved (100 mesh) and set aside. Weigh 500g, add petroleum ether at a solid-liquid ratio of 1:5 (g / mL) to defat until the petroleum ether layer is colorless, filter, and air-dry the powder naturally. The defatted powder is further decolorized with 85% ethanol at a solid-liquid ratio of 1:5 (g / mL) until the ethanol layer is lighter in color, filter, and air-dry the powder naturally for use. The decolorized and defatted seabuckthorn leaf polysaccharide is extracted by hot water extraction. Weigh 20g of powder and extract at a solid-liquid ratio of 1:20g / mL, extraction temperature of 90°C, and extraction time of 2h. After the extraction is completed, cool the extract to room temperature, filter, concentrate to 1 / 3 of the original volume, precipitate with anhydrous ethanol, place at 4°C for 12h, centrifuge, re-dissolve the precipitate, and freeze-dry to obtain crude polysaccharides from seabuckthorn leaves with a yield of 5.7±1.3%.

[0047] 1.2 Impurity removal of crude polysaccharide from seabuckthorn leaves: Weigh 5g crude polysaccharide from seabuckthorn leaves, dissolve in 500mL distilled water, centrifuge (4000r / min, 10min) after full dissolution, pass through AB-8 macroporous resin for deproteinization and decolorization, sample concentration 2mg / mL, elution volume 1BV, elution flow rate 2BV / h. The protein content of the solution before and after adsorption was measured using a BCA kit, and the protein content after adsorption was calculated to be 4.89%.

[0048] 1.3 Isolation and purification of seabuckthorn leaf polysaccharide: The solution after impurity removal was separated and purified by DEAE fast flow anion exchange column chromatography, with distilled water, 0.2 and 0.4 mol / L NaCl solution as eluents, respectively, at a flow rate of 2 mg / mL, collected by an automatic collector, and detected by anthrone-sulfuric acid method (0.2%), and the elution curve was drawn. The results are shown in the attached figure. Figure 1 , a neutral polysaccharide and two acidic polysaccharides were separated and named as HRLP-Ⅰ, HRLP-Ⅱ and HRLP-Ⅲ. According to the elution curve, it can be concluded that HRLP-Ⅱ is the main sugar in the seabuckthorn leaf polysaccharide of the present invention. Samples were collected according to the position of the elution peak and concentrated. The distilled water elution part (neutral polysaccharide) was directly freeze-dried; the NaCl solution elution part (acidic polysaccharide) was dialyzed (molecular weight cutoff 3500Da) for 48 hours and then freeze-dried. 100 mg of the freeze-dried HRLP-Ⅱ was weighed and purified by Superdex-75 gel column chromatography, eluted with distilled water at a flow rate of 0.4 mL / min, collected by an automatic collector, and detected by the anthrone-sulfuric acid method. The elution curve was drawn. The results are shown in the attached figure. Figure 2 , two molecular weight sugars were separated and named HRLP-Ⅱ-a and HRLP-Ⅱ-b. Samples were collected according to the elution peaks and freeze-dried to obtain uniform polysaccharides.

[0049] 1.4 Infrared spectra of HRLP-Ⅰ, HRLP-Ⅱ and HRLP-Ⅲ

[0050] Wipe the sample table gently with a cotton ball soaked in anhydrous ethanol, put a small amount of solid sample on it after drying, and spread it flat for testing. Use an infrared absorption spectrometer to measure the 4000-500cm -1 Infrared spectrum in the range.

[0051] From the attached Figure 3 It can be seen that the three polysaccharides are all in the range of 4500-500 cm -1 Typical infrared absorption peaks are shown in the range of 3280cm -1 The peak near 2900cm is caused by the stretching vibration of hydroxyl OH. -1 The absorption peak near 1745cm is the CH stretching vibration peak of -CH3. -1The absorption peak at 1630 cm-1 is the C=O stretching vibration peak, indicating the presence of uronic acid in HRLP-Ⅱ. The absorption peak near 1630 cm-1 is the hydration vibration peak of sugars. -1 The three weak absorption peaks in the range indicated that both polysaccharides were pyranose.

[0052] Example 2: Structural Identification of Seabuckthorn Leaf Homogeneous Polysaccharide HRLP-II-b

[0053] 2.1 High performance gel permeation (HPGPC) chromatogram of HRLP-Ⅱ-b

[0054] HPGPC method was used, and high-performance gel permeation chromatography series columns were used for detection. Instrument: Waters high-performance liquid chromatograph; Detector: Waters differential detector; Chromatographic column: 3 polymer-based water-soluble SEC (GFC) chromatographic columns (8×300mm) connected in series; Mobile phase: 0.05M NaCl solution; Flow rate: 0.65ml / min; Column temperature: 40℃; Injection volume: 30μL.

[0055] 2.1.1 Establishment of molecular weight calibration curve

[0056] Dextran standards of different molecular weights (molecular weight 1000, 5000, 12000, 25000, 50000, 80000, 150000, 270000, 410000, 670000 series analytical standards) were accurately weighed, and 0.05M NaCl solution was added to prepare 5 mg / mL dextran standard solutions, which were filtered through a 0.22 μm microporous filter membrane for later use. The HPGPC method was used with high-performance gel permeation chromatography tandem columns for detection, and linear regression was performed with the logarithm of the relative molecular mass of the standard as the ordinate and the retention time of the corresponding chromatographic peak as the abscissa to obtain a calibration curve.

[0057] The logarithmic value of the relative molecular mass of the standard was used as the ordinate and the retention time (T) of the corresponding chromatographic peak was used as the abscissa for linear regression to obtain the calibration curves of Log Mp-T (peak molecular weight), Log Mw-T (weight average molecular weight), and Log Mn-T (number average molecular weight), as shown below: Log Mw-T calibration curve equation: Log Mw = -0.1761T + 11.0299, R 2 =0.9927Log Mn-T calibration curve equation: Log Mn = -0.1674T + 10.5361, R 2 =0.9937Log Mp-T calibration curve equation: Log Mp = -0.1678T + 10.6291, R 2 =0.9916

[0058] 2.1.2 Preparation of test sample solution

[0059] Weigh 5 mg of sample accurately, add 1 mL of 0.05 M NaCl solution to the sample to prepare a 5 mg / mL test sample solution, centrifuge at 8000 rpm for 10 min, filter the supernatant with a 0.22 μm microporous membrane, and then transfer the sample to a 2 mL injection bottle for later use. Figure 4 As shown in Table 1, HRLP-Ⅱ-b is a homogeneous polysaccharide with a purity of 96.44%, a molecular weight of 14.18 kDa, and a distribution coefficient of 1.43. Table 1 HRLP-Ⅱ molecular weight and purity test results

[0060] 2.2 Monosaccharide composition of HRLP-Ⅱ-b

[0061] A high performance liquid chromatography system was used: Thermo U3000 liquid chromatography system, the chromatographic column was ZORBAX Eclipse XDB-C18, the mobile phase was acetonitrile: phosphate buffer (12 g / L potassium dihydrogen phosphate, 2 M NaOH adjusted the pH to 6.8) for isocratic elution, the volume ratio of acetonitrile to phosphate buffer was 17:83, the flow rate was 0.8 mL / min, the column temperature was 30 °C, the detection wavelength was 250 nm, and the injection volume was 10 μL.

[0062] The monosaccharide composition of HRLP-II-b was determined by PMP pre-column derivatization method. Figure 5 As shown in Table 2, the content of GalA (galacturonic acid) in the sample is the highest, indicating that HRLP-Ⅱ is a typical acidic polysaccharide, which is highly consistent with the previously measured uronic acid content of HRLP-Ⅱ, which is as high as 73%. HRLP-Ⅱ-b is composed of rhamnose (Rha): glucuronic acid (GlcA): galacturonic acid (GalA): galactose (Gal): arabinose (Ara) in a molar ratio of 3.20: 2.63: 83.24: 6.04: 4.81. The molar ratio results are shown in Table 2. Table 2 Monosaccharide composition of HRLP-Ⅱ-b (molar ratio) Note: "-" in the table means not detected

[0063] 2.4 Methylation results of HRLP-Ⅱ-b

[0064] 2.4.1 Chromatographic parameters: The chromatographic system used was an Agilent gas chromatography system (Agilent 7890A; Agilent Technologies, USA), an HP-5MS capillary column (30 m × 0.25 mm × 0.25 μm, Agilent J&W Scientific, Folsom, CA, USA), a carrier gas of high-purity helium (purity not less than 99.999%), a flow rate of 1.0 mL / min, and an injection port temperature of 260 °C. The injection volume was 1 μL, split injection, split ratio 10:1, and solvent delay 2.2 min. Program temperature rise: 50 °C for 1.0 min, 50 °C / min to 130 °C, 3 °C / min to 230 °C, and hold for 2 min.

[0065] 2.4.2 Mass spectrometry parameters: The mass spectrometry system used was a quadrupole mass spectrometry detection system (Agilent 5977B; Agilent Technologies, USA) from Aiglent, USA, equipped with an electron impact ion source (EI) and a MassHunter workstation. The electron impact ion source (EI), injection port temperature was 230°C, quadrupole temperature was 150°C, and electron energy was 70 eV. The scanning mode was full scan mode (SCAN), and the mass scanning range (m / z): 30-600.

[0066] 2.4.3 Sample derivatization: Weigh 10 mg of sample, add 1 mL of primary water to dissolve, add 1 mL of 100 mg / mL carbodiimide, react for 2 h; add 1 mL of 2 M imidazole, add 1 mL of 30 mg / mL NaBD4, react for 3 h; add 100 μL of glacial acetic acid to terminate the reaction. Dialyze the sample for 48 h, freeze-dry the sample after dialysis, and perform methylation treatment; add 500 μL of DMSO to the freeze-dried sample to dissolve; accurately weigh 1 mg of the sample to be tested, add 500 μL of DMSO to dissolve; add 1 mg of NaOH and incubate for 30 min; add 50 μL of iodomethane solution to react for 1 h; add 1 mL of water and 2 mL of dichloromethane, vortex to mix, centrifuge, and discard the aqueous phase. Repeat the water washing for 3 times; absorb the lower dichloromethane phase and evaporate to dryness; add 100μL of 2M TFA, react at 121℃ for 90min; evaporate to dryness at 30℃; add 50μL of 2M ammonia water, 50μL of 1M NaBD4, mix well, and react at room temperature for 2.5h; add 20μL of acetic acid to terminate the reaction, blow dry with nitrogen, wash twice with 250μL of methanol, blow dry with nitrogen; add 250μL of acetic anhydride, vortex mix well, react at 100℃ for 2.5h; add 1mL of water and let stand for 10min; add 500μL of dichloromethane, vortex mix well, centrifuge, and discard the aqueous phase. Repeat the water washing for 3 times; take the lower dichloromethane phase and detect on the machine. The results are as attached. Figure 6 shown.

[0067] According to the attached Figure 6 The inferred methylation results are shown in the following table: Table 3 Methylation results of HRLP-II-b

[0068] Example 3: Antioxidant activity of seabuckthorn leaf polysaccharides

[0069] 3.1 In vitro antioxidant activity

[0070] 3.1.1 ABTS free radical scavenging ability

[0071] HRLP-Ⅰ, HRLP-Ⅱ and HRLP-Ⅲ samples were prepared into sea buckthorn leaf polysaccharide samples with a concentration of 4 mg / mL, diluted to different gradients, ABTS with an absorbance value of 0.70±0.02 (734nm) was added, mixed, reacted at room temperature for 5 minutes, and the absorbance (734nm) was measured. Distilled water was used instead of ABTS as the control group, and distilled water was used instead of the sample as the blank group. The clearance rate was calculated according to the following formula (1): Where: A i : absorbance of sample group; A j : absorbance of the control group; A0: absorbance of the blank group.

[0072] 3.1.2 DPPH free radical scavenging ability

[0073] HRLP-Ⅰ, HRLP-Ⅱ and HRLP-Ⅲ samples were prepared into sea buckthorn leaf polysaccharide samples with a concentration of 4 mg / mL, diluted to different gradients, added with 100 μL of freshly prepared DPPH-methanol solution, reacted at a constant temperature and in the dark for about 30 minutes, and the absorbance (517 nm) was measured. Methanol was used instead of DPPH-methanol solution as a control group, and distilled water was used instead of the sample as a blank group. The clearance rate was calculated according to formula (1).

[0074] 3.1.3 Hydroxyl radical scavenging ability

[0075] HRLP-Ⅰ, HRLP-Ⅱ and HRLP-Ⅲ samples were prepared into sea buckthorn leaf polysaccharide samples with a concentration of 4 mg / mL, and 200 μL of sample solutions of different concentrations were prepared. 200 μL of freshly prepared ferrous sulfate solution and 200 μL of salicylic acid-ethanol solution were added, mixed, and then 200 μL of hydrogen peroxide (0.1%) solution was added. The solution was incubated at 37°C for 30 min, and the absorbance was measured at 510 nm. Distilled water was used instead of hydrogen peroxide as a control group, and distilled water was used instead of the sample as a blank group. The clearance rate was calculated according to formula (1).

[0076] 3.1.4 Ferrous ion chelation capacity

[0077] HRLP-Ⅰ, HRLP-Ⅱ and HRLP-Ⅲ were prepared into sea buckthorn leaf polysaccharide samples with a concentration of 4 mg / mL. 200 μL of sample solutions of different concentrations were taken, 20 μL of ferrous chloride solution and 40 μL of phenanthroline solution were added, mixed, reacted at room temperature for 5 min, and the absorbance was measured at 562 nm. Distilled water was used instead of phenanthroline as the control group, and distilled water was used instead of the sample as the blank group. The clearance rate was calculated according to formula (1).

[0078] 3.1.5 Total reduction capacity

[0079] HRLP-Ⅰ, HRLP-Ⅱ and HRLP-Ⅲ were prepared into sea buckthorn leaf polysaccharide samples with a concentration of 4 mg / mL. 800 μL of polysaccharide solutions of different concentrations were accurately measured, 400 μL of PBS (0.2M, pH 6.6) and 400 μL of potassium ferrocyanide solution (1%) were added, mixed, reacted at a constant temperature of 50°C for 50 minutes, taken out, and cooled to room temperature; 400 μL of 10% TCA aqueous solution was added (if a precipitate is generated in the solution, centrifugation is required), 1600 μL of distilled water and 400 μL of ferric chloride aqueous solution (0.1%) were added, and the solution was placed at room temperature for 10 minutes, and the absorbance was measured at 700 nm.

[0080] From the attached Figure 7 It can be seen that HRLP-Ⅰ has the best ABTS, DPPH and hydroxyl radical scavenging ability and total reducing ability, and the three polysaccharides have average ferrous ion chelating ability. Although the clearance rates of HRLP-Ⅱ and HRLP-Ⅲ are lower than BHT, they show an overall upward trend with the increase of concentration and are not much different from the positive control.

[0081] Example 4: Study on the mechanism of immunomodulatory effect of purified polysaccharide HRLP-Ⅱ-b from seabuckthorn leaves on macrophage RAW264.7

[0082] 4.1 Cell experiments

[0083] Experimental materials: mouse RAW264.7 macrophage cell line; seabuckthorn leaves; DMEM culture medium (Vivacell); fetal bovine serum (Vivacell); LPS (Shanghai Yuanye Biotechnology); TNF-α, IFN-γ, IL-4, IL-10 enzyme-linked immunosorbent assay (ELISA) kits (Shanghai Fanke Industrial Co., Ltd.); CCK8 (Wuhan Sanying Biotechnology Co., Ltd.), Trizol lysis buffer (Beijing Solebold Technology Co., Ltd.); 2×Rapid Taq Master Mix, HiScript Ⅲ1st Strand cDNASynthesis Kit (+gDNA wiper) and HiScript Ⅲ RT SuperMix for qPCR (+gDNAwiper) (Nanjing Novogene Biotechnology Co., Ltd.); BioGold SYBR qPCR master mix (Zhejiang Bolkin Technology Co., Ltd.). CO2 incubator (Thermo Fisher Scientific); microplate reader (BioTek Instruments, Inc); QIAamplifier 96PCR amplification instrument (QIAGEN); ABI 7500 fluorescence quantitative PCR instrument (Beijing Hongda Hengye Technology Co., Ltd.); TDL-40B centrifuge (Shanghai Anting Scientific Instrument Factory).

[0084] 4.2 Cell culture

[0085] RAW264.7 cells were cultured in DMEM complete medium (containing 10% FBS, 2% double antibody) in a cell culture incubator at 37°C and 5% CO2. Cells in the logarithmic growth phase were used for the experiment.

[0086] 4.3 CCK8 assay to detect cell viability

[0087] The CCK8 method is a highly sensitive, non-radioactive cell proliferation or toxicity detection method. It generates formazan through the reduction of WST-8 by living cell mitochondria, and the color depth reflects the cell activity. It can be used for cell proliferation, drug screening, toxicity determination, etc. Based on previous experiments, we use the CCK8 method to detect cell activity.

[0088] Experimental steps: Take cells in logarithmic growth phase and adjust the density to 5×10 5 / mL, inoculated in a 96-well plate, 150 μL per well; cultured in groups, discarded the supernatant after 24 hours, added complete medium containing medicine, the concentrations of seabuckthorn leaves were 1, 0.5, 0.25, 0.125, 0.0625, 0.03125, 0.015625 mg / mL, respectively, and set up a blank group and a control group; discarded the supernatant after 24 hours, added complete medium containing 10% CCK8, 100 μL per well, detected OD value at 450 nm after 1 hour, and calculated cell viability according to formula (2).

[0089] The experiment describes the effect of different concentrations (0.015625-1 mg / mL) of seabuckthorn leaf polysaccharide on the survival rate of macrophage RAW264.7. The results are shown in the attached figure. Figure 8 The results showed that compared with the control group, the cell survival rate of the seabuckthorn leaf group was significantly increased (P < 0.05), indicating that within the range of 0.015625-1 mg / mL, the polysaccharide administration group within the experimental concentration had no cytotoxicity to macrophages (survival rate greater than 100%), and could promote the proliferation of RAW264.7 cells, among which the cell survival rate was the highest at a concentration of 0.015625 mg / mL (P < 0.05). Between the concentrations of 0.0625 and 1 mg / mL, the survival rate of RAW264.7 cells was relatively stable (P > 0.05), but there was no dose-dependency. In the subsequent experiment, a dose of 0.25 mg / mL will be selected for research.

[0090] 4.4ELISA method to detect the content of TNF-α, IL-4, IFN-γ and IL-10 in cell supernatant

[0091] Take cells in logarithmic growth phase and adjust the density to 5×10 5 / mL, inoculated in a 6-well plate, 2mL per well; cultured in groups, discarded the supernatant after 24h, added drug-containing complete culture medium for intervention for 8h, the drug concentration was 250μg / mL, and set up a control group (containing only complete culture medium) and LPS group. After culture for 12h, the supernatant was taken, and the TNF-α, IL-4, IFN-γ and IL-10 contents were detected according to the instructions of the ELISA kit.

[0092] The results are attached Fig. 9 As shown, compared with the control group, the contents of TNF-α, IL-4, IFN-γ and IL-10 in the LPS group and seabuckthorn leaf group were significantly increased (P < 0.05), indicating that seabuckthorn leaf polysaccharide at 0.25 mg / mL can promote the secretion of TNF-α, IL-4, IFN-γ and IL-10 by RAW264.7 cells.

[0093] 4.5 RT-qPCR detection of cell-related mRNA expression

[0094] Treat the cells according to "4.4", collect the cells, extract total RNA according to the Trizol method; reverse transcribe the RNA into cDNA according to the reverse transcription instructions: 42℃2min; 50℃15min; 85℃5s; then use a PCR instrument for amplification. The primers were synthesized by Xinjiang Youkang Biotechnology Co., Ltd., with GAPDH as the internal reference. The primer sequences are as follows: Table 4 Primer sequences

[0095] 4.5.1 Overall genetic changes

[0096] As shown in the volcano map (attached Fig.10 ) showed that compared with the CON group, there were 1829 genes with clear changes in the seabuckthorn leaf group, including 758 up-regulated genes and 1071 down-regulated genes. These significantly differentially expressed genes screened out will help to combine KBGG enrichment analysis to clarify the changes in gene expression and regulatory mechanisms during biological regulation.

[0097] 4.5.2 KEGG enrichment analysis

[0098] The KEGG biological pathway enrichment analysis was used to analyze the biological pathways significantly affected by seabuckthorn leaves, and the top 8 pathways with the largest number of involved genes were visualized, as shown in the bubble diagram (see Figure 2). Fig.11 ) are shown in Figure 2. Including TNF signaling pathway (tumor necrosis factor signaling pathway), NF-kappa B signaling pathway (NF-κB signaling pathway), Small cell lung cancer (small cell lung cancer), Toll-like receptor signaling pathway (Toll-like receptor signaling pathway), Lipid and atherosclerosis (lipid and atherosclerosis), JAK-STAT signaling pathway (Janus kinase-signal transducer and activator of transcription signaling pathway), NOD-like receptor signaling pathway (NOD-like receptor signaling pathway), Pathways in cancer (cancer pathway). Among them, the two pathways closely related to inflammatory response are NF-κB and Toll-like receptor signaling pathways.

[0099] 3.5.3 Pathway gene analysis

[0100] In order to further analyze the immunomodulatory pathway of HRLP-Ⅱ-b on macrophage RAW264.7, the present invention drew a pathway diagram (see Appendix Fig.12 ) and heatmap (attached Fig.13) to analyze the changes in specific genes in its related pathways. Fig.19 As shown, there are 27 and 22 genes closely related to immune regulation respectively (the same genes have been merged). Through the above cell experiments, the present invention preliminarily speculates that seabuckthorn leaf polysaccharide HRLP-Ⅱ-b can enhance the immune regulation of mouse macrophages RAW264.7, and its mechanism may be related to NF-κB and Toll-like receptor signaling pathways.

[0101] Example 5: Immunomodulatory activity of seabuckthorn leaf polysaccharide HRLP-Ⅱ

[0102] 5.1 Animal experiments

[0103] Animal grouping and sample collection: 90 female BALB / c mice (18-22g) were randomly divided into blank group, model group, positive control group, high-dose group, medium-dose group, and low-dose group, with 15 mice in each group, and adaptively raised at 22±2℃, 12h light-dark cycle for 7 days; the mice in the blank group were intraperitoneally injected with normal saline, and the other mice were intraperitoneally injected with cyclophosphamide 70mg / kg for 3 consecutive days to establish an immunosuppressed mouse model; then the blank group and the model group were gavaged with normal saline, and the low, medium, and high-dose groups were gavaged with 100, 200, and 400mg / kg BW of HRLP-Ⅱ solution, 0.2mL / 20g, and were killed after 7 consecutive days of treatment.

[0104] 5.2 Effect of HRLP-Ⅱ on body weight changes in mice

[0105] Body weight can reflect the health status of an organism to a certain extent. The changes in body weight of mice in each group during the feeding period are shown in the attached figure. Fig.14 As shown. The weight of mice was measured, and it was found that during the first 7 days of adaptive feeding, the weight of mice in each group continued to increase, and the weight changes of experimental mice in each group remained close, with no significant difference (P>0.05); during the 3 days of intraperitoneal injection of cyclophosphamide, except for the blank group, which continued to increase slowly, the weight of the other mice continued to decrease, indicating that cyclophosphamide may have damaged the immune system of mice; in the last 7 days of treatment, the weight of mice in the model group increased slowly, and the average weight growth rate of mice in the positive control group and high and low doses of HRLP groups was higher than that of the other groups. The results showed that HRLP-Ⅱ can effectively improve the weight loss of mice caused by cyclophosphamide-induced immunosuppressed mice.

[0106] 5.3 Effects of HRLP-Ⅱ on organ indexes of mice

[0107] After 21 days, the mice were weighed and recorded as the final body weight G. After collecting serum, the mice were killed and dissected. The liver, kidney, heart, lung and spleen were removed and washed with physiological saline. After absorbing water, they were weighed and the index of each organ was calculated according to formula (3).

[0108] The indexes of various organs are shown in Table 5 below. Compared with the blank group, the indexes of various organs in the model group were basically decreased (P<0.05), indicating that the model was successful. Compared with the model group, the organ indexes of the spleen in the other groups were significantly increased (P<0.05), among which the organ indexes of the medium-dose group were higher than those in the model group (P<0.05), indicating that the medium-dose group can better improve the organ damage induced by cyclophosphamide in immunosuppressed mice. Table 5 Effects of HRLP-Ⅱ on organ indexes of mice

[0109] 5.4 Effects of HRLP-Ⅱ on mouse serum factors

[0110] Mouse serum was collected and the inflammatory factors IL-2, IL-4, IL-6, IL-10, IL-17, TNF-ɑ, and IFN-γ in mouse serum were determined according to the ELISA kit operating instructions. The results are shown in the attached Fig.15 As shown in the figure, the levels of IL-2, IL-4, IL-6, IL-10, IL-17 and TNF-ɑ in the model group were higher than those in the blank group (P<0.05), indicating that the modeling was successful. Compared with the model group, the positive group and the high, medium and low dose groups had different degrees of decrease in serum factors, especially the decrease in IL-10 and TNF-ɑ was the most obvious (P<0.05). The content of IFN-γ did not change much, but it was also slightly reduced in the positive group and the medium and low dose groups compared with the model group. The results showed that seabuckthorn leaf polysaccharide HRLP-Ⅱ could alleviate the pathological phenomenon of increased inflammatory factors in the serum of suppressed mice induced by cyclophosphamide.

[0111] 5.5 Effect of HRLP-Ⅱ on short-chain fatty acids in mice

[0112] The content of short-chain fatty acids in mouse feces was detected by gas chromatography: Thermo Fisher fully automatic gas chromatograph (TRACE1300 / 1310), gas chromatograph parameters: column oven temperature 150°C, equilibration time 3 minutes, front inlet temperature 220°C, front detector temperature 210°C, carrier gas is nitrogen, hydrogen, oxygen.

[0113] Standard samples: Use centrifuge tubes to weigh 0.9100g of chromatographic standard grade acetic acid, 0.3700g of propionic acid, 0.1765g of butyric acid, 0.1765g of isobutyric acid, 0.1985g of valeric acid and 0.1985g of isovaleric acid, mix well and add to a 100mL volumetric flask (rinse the centrifuge tube with double distilled water several times to ensure that all the contents of the centrifuge tube are transferred to the volumetric flask), and finally dilute to 100mL. Then dilute 100mL of the standard by 2 times, 5 times, 10 times, 20 times, 30 times, 40 times, 50 times, and 100 times to establish a standard curve; Preparation of internal standard metaphosphoric acid solution: Prepare a 25% w / v metaphosphoric acid solution, dissolve 25g of metaphosphoric acid in 100mL of double distilled water, add 0.6464g of crotonic acid to the 100mL metaphosphoric acid solution, and dilute to 100mL.

[0114] Determination of fecal samples: Weigh 1g of fecal samples from each group and place them in a centrifuge tube, add 5-10 times of distilled water, and mix well. Take 1mL of supernatant, add 0.2mL / mL of metaphosphoric acid, centrifuge, and take the supernatant.

[0115] Same as sample treatment, add 0.2mL of a mixture of metaphosphoric acid and crotonic acid to 1mL of standard sample, and measure the retention time of acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, and isovaleric acid (ensure that the standard sample is treated the same as the sample). Add 1mL of ether to 1mL of sample (ether and sample are extracted at a volume ratio of 1:1), vortex and mix well (ensure complete extraction), and use a pipette to draw the supernatant after extraction and add it to the liner in the injection bottle (the injection bottle cap needs to be tightened to prevent volatilization). Load the sample to detect short-chain fatty acids.

[0116] As can be seen from Table 6, compared with the blank group, the content of acetic acid, propionic acid, butyric acid and valeric acid in the model group decreased to varying degrees (P<0.05), and the content of each short-chain fatty acid in the positive group, high-, medium- and low-dose groups increased compared with the model group, especially in the high-dose group (P<0.05). The results showed that seabuckthorn leaf polysaccharide HRLP-Ⅱ can promote the synthesis of short-chain fatty acids in the intestine of cyclophosphamide-induced immunosuppressed mice. Table 6 Effects of HRLP-Ⅱ on short-chain fatty acids in mice

[0117] 5.6 Effects of HRLP-Ⅱ on the spleen of immunosuppressed mice

[0118] 5.6.1 Effects on spleen inflammatory factors IL-2, IL-6, and TNF-α

[0119] The spleen of the mouse was taken, ground and centrifuged to obtain the supernatant, and the inflammatory factors IL-2, IL-6, and TNF-ɑ in the spleen of the mouse were determined according to the operating instructions of the ELISA kit. The results are shown in the attached Fig.17 As shown, the results showed that the inflammatory factors in the model group increased to varying degrees compared with the blank group (P < 0.05), among which TNF-α increased most significantly, indicating that the model was successful. Compared with the model group, the positive group and the high, medium and low dose groups had different degrees of decreases in the content of inflammatory factors (P < 0.05), among which IL-2 and IL-6 had the lowest content in the high and medium doses, TNF-α had the lowest content in the positive group, and the low dose group was second. The results showed that seabuckthorn leaf polysaccharide HRLP-Ⅱ can alleviate the pathological phenomenon of increased inflammatory factors in the spleen of suppressed mice induced by cyclophosphamide.

[0120] 5.6.2 HE staining results of mouse spleen

[0121] HE staining steps: pour out the culture medium, wash 3 times with PBS, 5 minutes each time; fix with 4% paraformaldehyde for 10-20 minutes, wash 3 times with PBS, 5 minutes each time; treat with lapis lazuli blue dye for 3 minutes, wash with PBS; add hematoxylin dye solution to the well, stain for 3-10 minutes, wash with PBS; differentiate with 1% hydrochloric acid, wash with PBS, turn blue with 1% ammonia water, wash with PBS; add eosin dye solution to the well, stain for 1-3 minutes; wash twice with 95% alcohol and once with anhydrous ethanol; take out the slide, dehydrate with alcohol xylene to make it transparent, seal with neutral gum or do not dehydrate and seal with glycerol gelatin.

[0122] The results of HE staining of spleen of immunosuppressed mice are shown in the attached figure. Fig.18 As shown in the figure, the results showed that the density of lymphoid sheath cells around the splenic artery of the blank group mice was normal, there was no hyperplasia in the marginal zone, a small amount of red blood cells were mixed, and there was no congestion in the red pulp. Compared with the blank group, the marginal zone of the model group was significantly widened, severe lymph node hyperplasia, the proportion of white blood cells increased, the white pulp boundary was blurred, the red pulp was severely congested, the inherent cell components in the red pulp were reduced, and the pathological damage was severe. Compared with the model group, the density of lymphoid sheath cells around the splenic artery of the positive group and the seabuckthorn leaf polysaccharide administration group mice was normal, there was mild lymph node hyperplasia, mild widening of the marginal zone, and mild congestion of the red pulp. It shows that seabuckthorn leaf polysaccharide HRLP-Ⅱ can alleviate the spleen tissue pathological changes induced by cyclophosphamide in immunosuppressed mice.

[0123] 5.6.3 Mouse spleen flow cytometry results

[0124] The spleen is the largest peripheral immune organ, containing a large number of T cells and B cells. It is the main place for mature lymphocytes to settle and for lymphocytes to produce immune responses to blood-borne antigens. Lymphocytes include T lymphocytes (CD3 + ), B lymphocytes (CD3 - CD19 +), NK cells (CD3 - CD16 + CD56 + ), among which T cells are the main components of lymphocytes. CD4 is commonly referred to as auxiliary / inducing T lymphocytes (CD3 + CD4 + ), CD4 + The correct cell for T lymphocytes is a cell that is both CD3 and CD4 positive. CD8 is a suppressor / cytotoxic T lymphocyte (CD3 + CD8 + ), CD8 + T lymphocytes are cells that are positive for both CD3 and CD8. + CD4 + stands for T helper / inducer cell subset (abbreviated as CD4); CD3 + CD8 + Represents T suppressor / cytotoxic cell subset (abbreviated as CD8); CD3 + CD4 + / CD3 + CD8 + It stands for the ratio of T helper cells to T suppressor cells (abbreviated as CD4 / CD8 ratio). Since HIV attacks CD4 cells in the human body, the CD4 count can directly reflect the human immune function and is the most clear indicator of the damage to the immune system of HIV-infected patients. The absolute count of CD4 cells usually fluctuates greatly depending on the physiological conditions, while the ratio of CD4 to CD8 is relatively stable. The frequency of opportunistic infections in HIV / AIDS patients is closely related to the CD4 cell count and the CD4 / CD8 ratio. + When the T cell count is less than 200 and the CD4 / CD8 ratio is less than 0.20, the chance of opportunistic infections increases significantly, and the chance of multiple opportunistic infections occurring simultaneously increases significantly as the disease progresses. Under normal circumstances, the CD4 / CD8 ratio is between 1.5 and 2.5.

[0125] Preparation of spleen single cell suspension: Take 5 spleens from each group of mice and place them in a 5mL centrifuge tube containing a certain volume of PBS; add a matching 100μm cell sieve to the 50mL centrifuge tube, pour the spleen tissue into the cell sieve and grind it, add PBS to rinse while grinding, until there is no obvious spleen tissue in the cell sieve; place the filtered sample in a centrifuge at 1500r / min and 4℃ for 5min; take out the centrifuge tube, discard the supernatant, resuspend the cells with red blood cell lysis buffer, and place at room temperature for 3min; add 5mL PBS to terminate the red blood cell lysis process; place the sample after the termination of red blood cell lysis in a centrifuge at 1500r / min and 4℃ for 5min; discard the supernatant, resuspend the cell pellet with PBS, observe the cell density under a microscope, and keep it consistent for each group.

[0126] Flow cytometric antibody labeling and detection: (1) local (without antibody); (2) single labeling (with anti-CD3-FITC and anti-CD4-APC antibodies respectively); (3) mixed labeling with anti-CD3-FITC and anti-CD4-APC, incubate for 45 min, wash twice with PBS, and detect T cell differentiation by flow cytometry.

[0127] The results of spleen flow cytometry are shown in the attached Fig.19 As shown, the results showed that T lymphocytes in local antibodies accounted for 60.3% of the total lymphocytes, of which CD3 accounted for 47.2% of the T lymphocytes. Q1 is CD4 - CD8 + , Q2 is CD4 + CD8 + , Q3 is CD4 + CD8 - , Q4 is CD4 - CD8 - , that is, Q1 is CD8 + Cell percentage, Q3 is CD4 + Cell ratio, calculate CD4 based on the image ratio + / CD8 + The ratios are shown in Table 7 below. The results show that the ratio of the blank group was 2.36, and that of the model group was 1.85, which was 0.51 lower than that of the blank group, indicating that the model was successfully established. Compared with the model group, the ratios of the positive group and the high, medium and low dose groups increased, among which the high dose group had the highest ratio, reaching 2.39. This indicates that HRLP-Ⅱ can alleviate the cyclophosphamide-induced spleen T lymphocyte pathology in immunosuppressed mice and can reduce the chance of viral infection in mice to a certain extent. Table 7 Mouse spleen flow cytometry results

[0128] 5.7 Effects of HRLP-Ⅱ on the intestinal tract of mice

[0129] 5.7.1 Effects of HRLP-Ⅱ on intestinal inflammatory factors IL-2, IL-4, IL-10, IL-17, TNF-α, and IFN-γ in mice

[0130] The jejunum, ileum and duodenum of mice were collected, ground and centrifuged to obtain the supernatant, and the inflammatory factors IL-2, IL-4, IL-10, IL-17, TNF-α and IFN-γ in the mouse intestine were determined according to the instructions of the ELISA kit. The results are shown in the attached figure. Fig. 20 As shown, the results showed that the levels of IL-2, IL-4, IL-10, IL-17, TNF-α, and IFN-γ in different intestinal tracts of the model group were increased to varying degrees compared with the blank group (P < 0.05), indicating that the model was successful. In the jejunum, the medium-dose group had the lowest levels of IL-2, IL-10, TNF-α, and IFN-γ, and the low-dose group had the lowest levels of IL-4 and IL-17 (P < 0.05); in the ileum, the medium-dose group had the lowest levels of IL-4, IL-10, and IFN-γ, and the low-dose group had the lowest levels of IL-2, IL-17, and TNF-α; in the duodenum, the positive group had the lowest levels of IL-4 and TNF-α, the high-dose group had the lowest levels of IL-2 and IL-17, and the medium-dose group had the lowest levels of IL-10 and IFN-γ. In summary, the positive group and the high, medium and low dose groups in different intestines showed a decrease in different inflammatory factors compared with the model group (P < 0.05). The results showed that seabuckthorn leaf polysaccharide HRLP-Ⅱ can alleviate the pathological phenomenon of increased inflammatory factors in the intestine of suppressed mice induced by cyclophosphamide.

[0131] 5.7.2 HE staining results of HRLP-Ⅱ on mouse intestine

[0132] The experimental process is the same as 4.2.5. The experimental results are shown in the attached Fig.21 As shown in the figure, the tissue sections of the jejunum, ileum, duodenum and cecum of mice observed under an optical microscope showed that the intestinal mucosal structure of the blank group mice was intact, the intestinal villi were complete, the outline was clear and visible, and they were closely arranged; compared with the blank group, the intestinal wall of the model group mice was damaged, the intestinal villi structure was destroyed, the arrangement was loose, the villi height and crypt depth were reduced, and a large number of inflammatory cells infiltrated; after intervention with seabuckthorn leaf polysaccharide HRLP-Ⅱ, the epithelial damage in the medium and low dose groups was relatively mild, but there was still a large amount of inflammatory cell infiltration, while the intestinal villi morphology of the high dose group mice gradually recovered to the fence-like shape, and the villi structure was clear, the length increased, and the arrangement was close. The mucosal epithelial damage was mild, and there was no obvious inflammatory cell infiltration. This shows that seabuckthorn leaf polysaccharide alleviated the damage of cyclophosphamide to the intestinal mucosa of mice to a certain extent and protected the integrity of the intestinal mucosa.

[0133] 5.7.3 AB-PAS staining results of the effect of HRLP-Ⅱ on mouse intestine

[0134] Experimental steps: a) Dewaxing of paraffin sections: sequentially place paraffin sections in xylene I for 20 min-xylene II for 20 min-anhydrous ethanol I for 5 min-anhydrous ethanol II for 5 min-75% alcohol for 5 min, and rinse with tap water; b) Potassium dichromate staining: Soak paraffin sections in potassium dichromate solution overnight, and rinse with tap water; c) Iron hematoxylin staining: Iron hematoxylin A solution and B solution are mixed in equal proportions to form iron hematoxylin staining solution, place paraffin sections in iron hematoxylin for 3 min, rinse with tap water, differentiate with hydrochloric acid and alcohol for a few seconds, and rinse with tap water; d) Ponceau staining: Paraffin sections were dyed with Ponceau acid fuchsin solution for 5-10 minutes and quickly rinsed with tap water; e) Phosphomolybdic acid treatment: treated with phosphomolybdic acid aqueous solution for 1-3 minutes; f) Aniline blue staining: no need to wash with water after phosphomolybdic acid, directly dyed with aniline blue dye solution for 3-6 minutes; g) Differentiation: differentiated with 1% glacial acetic acid for a few seconds, dehydrated with two cylinders of anhydrous ethanol; h) Transparent sealing: paraffin sections were placed in anhydrous ethanol for 5 minutes, n-butanol for 5 minutes, and xylene for 5 minutes to make them transparent, took the sections out of xylene and dried them slightly, and sealed with neutral gum; i) Microscope examination, image acquisition and analysis.

[0135] In intestinal tissue, goblet cells are the main secretory cells. The mucus they secrete in the intestines forms a mucus barrier that plays an important role in maintaining the environmental homeostasis and health of the intestine. The results of AB-PAS staining are shown in the attached figure. Fig.21 As shown in the figure, the round objects in the figure are goblet cells. It can be seen from the figure that the goblet cells in the blank groups of the jejunum, ileum, duodenum and cecum are evenly distributed with moderate density, while the goblet cells in the model group are significantly increased, accompanied by a large number of inflammatory cell infiltration. After the intervention of seabuckthorn leaf polysaccharide HRLP-Ⅱ, the goblet cell density in the medium and high dose groups of the jejunum and duodenum was significantly reduced, and the distribution was even and there was no obvious inflammatory cell infiltration phenomenon; in the ileum, the goblet cells in the model group were accumulated in large quantities and the epithelial tissue was broken in large quantities. Compared with the model group, the goblet cells in the positive and high, medium and low dose groups were significantly reduced, and the intestinal state was significantly improved; the effect of the medium and low dose groups in the cecum was more obvious. It shows that seabuckthorn leaf polysaccharide alleviates the damage of cyclophosphamide to the intestinal mucus barrier of mice to a certain extent, and maintains the environmental state and health of the intestine.

[0136] Finally, it should be pointed out that the above are only some preferred embodiments of the present invention and should not be construed as limiting the scope of protection of the present invention. Some non-essential improvements and adjustments made by those skilled in the art based on the above contents of the present invention all fall within the scope of protection of the present invention.

Claims

1. A method for preparing a uniform polysaccharide from seabuckthorn leaves having an immunomodulatory effect, Features: The following steps are involved: 1) Crush the dried seabuckthorn leaves, pass through a 100-mesh sieve, reflux in ethanol at 90°C for 2 hours, and then air-dry the powder. Repeat this process three times until the ethanol layer becomes lighter in color. 2) The air-dried powder in step 1) was stirred with petroleum ether at room temperature for 2 hours and then continued to be air-dried. This was repeated three times until the petroleum ether layer was colorless. 3) The air-dried powder in step 2) is extracted with hot water at 95-100° C. for 2 hours, and then filtered with three layers of gauze and concentrated. 4) The concentrated solution in step 3) is centrifuged and dialyzed for 48 hours. After the dialysis, the concentrated solution is precipitated with anhydrous ethanol, centrifuged, and vacuum freeze-dried to obtain crude seabuckthorn leaf polysaccharide. 5) The crude polysaccharide in step 4) is dissolved in distilled water, centrifuged, and passed through AB-8 macroporous resin for deproteinization and decolorization. The solution after impurity removal is separated by an anion exchange column (DEAE Sepharose Fast Flow), and eluted with distilled water, 0.2, and 0.4 mol / L NaCl solution as eluents, respectively, collected by an automatic collector, and an elution curve is drawn. The samples were collected according to the position of the elution peak, concentrated, the distilled water elution portion (neutral polysaccharide) was directly freeze-dried, and the NaCl solution elution portion (acidic polysaccharide) was dialyzed for 48 hours and then freeze-dried. 6) Weigh 100 mg of the main polysaccharide after freeze-drying in step 5) and purify it through a gel column (Superdex-75), elute with distilled water, collect it with an automatic collector, draw an elution curve, collect samples according to the elution peak, and freeze-dry to obtain a uniform polysaccharide.

2. The method for preparing the uniform polysaccharide from seabuckthorn leaves according to claim 1, It is characterized in that The anion exchange column used in step 5) is a DEAE Sepharose FastFlow chromatography column with a flow rate of 5 mL / min, and the dextran gel in step 6) is a Superdex-75 chromatography column with a flow rate of 0.4 mL / min. The elution curve is tracked by the anthrone-sulfuric acid method.

3. The seabuckthorn leaf polysaccharide according to claim 2, It is characterized in that The galacturonic acid content is 83.24%.

4. The seabuckthorn leaf polysaccharide according to any one of claims 2 to 3, It is characterized in that The average molecular weight is 14.18×10 3 Da is an acidic heteropolysaccharide composed of monosaccharides rhamnose, glucuronic acid, galacturonic acid, galactose and arabinose. The molar ratio of rhamnose, glucuronic acid, galacturonic acid, galactose and arabinose is 3.20:2.63:83.24:6.04:4.

81.

5. Use of the seabuckthorn leaf acid polysaccharide according to any one of claims 1 to 3 in the preparation of immunomodulatory drugs, health products or foods.

Citation Information

Cited By

  • Betahistine hydrochloride ionic gel and preparation method thereof

    CN120360937A

  • Hippophae rhamnoides leaves uniform acidic polysaccharide, and preparation method and use thereof

    CN122832146A